A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/24/2011	US20110286967 Long-acting interferons and derivatives thereof and methods thereof
11/24/2011	US20110286966 Inhibitor of Endogenous Human Interferon-gamma
11/24/2011	US20110286965 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011	US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011	US20110286963 Human soluble cd146, preparation and uses thereof
11/24/2011	US20110286962 Compounds and pharmaceutical compositions for the treatment of viral infections
11/24/2011	US20110286961 Hepatitis C Virus Inhibitors
11/24/2011	US20110286960 Cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf)
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286948 Bacterial cellulose film and uses thereof
11/24/2011	US20110286939 Osteogenic compositions containing a coloring agent
11/24/2011	US20110286937 Synthetic glycolipid-containing liposome
11/24/2011	US20110286934 Membrane transduction peptides, polynucleotides, and methods
11/24/2011	US20110286928 Methods and compositions for inhibition of BCL6 repression
11/24/2011	US20110286927 ATF4 Inhibitors and Their Use for Neural Protection, Repair, Regeneration, and Plasticity
11/24/2011	US20110286926 Degradable hydrogel compositions and methods
11/24/2011	US20110286924 Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2802931A1 Novel glucagon like peptide analogs, composition, and method of use
11/24/2011	CA2800348A1 Il-12 formulations for enhancing hematopoiesis
11/24/2011	CA2799944A1 Methods and compositions related to modulating autophagy
11/24/2011	CA2799735A1 Biglycan mutants and related therapeutics and methods of use
11/24/2011	CA2799733A1 New uses of oxytocin-like molecules and related methods
11/24/2011	CA2799633A1 Improved anti-serum albumin binding variants
11/24/2011	CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
11/24/2011	CA2798988A1 Novel dna-binding proteins and uses thereof
11/24/2011	CA2792669A1 Long - acting formulations of insulins
11/23/2011	EP2388318A1 Antisense modulation of connective tissue growth factor expression
11/23/2011	EP2388317A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/23/2011	EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011	EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388023A1 Composites on a basis of bioceramics and biodegradable or non biodegradable polymers, containing antibiotics for tissue restitution and products therefrom
11/23/2011	EP2388013A2 C-reactive protein and its use to treat systemic Lupus erythematosus and related conditions
11/23/2011	EP2388012A1 Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
11/23/2011	EP2387989A2 Long - acting formulations of insulins
11/23/2011	EP2387581A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
11/23/2011	EP2387580A1 Deoxyactagardine derivatives
11/23/2011	EP2387420A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
11/23/2011	EP2387419A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor
11/23/2011	EP2387413A1 Protein conjugate having an endopeptidase-cleavable bioprotective moiety
11/23/2011	EP2387412A1 Methods for increasing adiponectin
11/23/2011	EP2387399A2 Food supplement for the treatment of neuropathies
11/23/2011	EP2387390A2 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/23/2011	EP2127667B1 Oral disinfectant and food additive comprising the disinfectant
11/23/2011	EP2084181B1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy
11/23/2011	EP1735439B1 Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1
11/23/2011	EP1727558B1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents
11/23/2011	EP1678305B1 Protozoan strain of the species leishmania infantum of reduced virulence and use thereof
11/23/2011	EP1592786B1 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
11/23/2011	EP1581254B1 Pharmacological vitreolysis using truncated plasmin
11/23/2011	EP1511772B1 Method for obtaining anti-idiotype antibodies
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1507787B1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011	EP0948358B2 Stable liquid interferon formulations
11/23/2011	CN1993467B Gene related with prostate disease and encoding polypeptides and its application
11/23/2011	CN1897973B Application of lactoferrin and polyinosinicacid in proliferation agent combinations of preparation of animal nature killer cells
11/23/2011	CN1832960B Immunomodulating compositions, uses therefor and processes for their production
11/23/2011	CN102257002A Truncated cd20 protein, deltacd20
11/23/2011	CN102257001A soluble polypeptides for use in treating autoimmune and inflammatory disorders
11/23/2011	CN102256995A Cyclic depsipeptide compound and use thereof
11/23/2011	CN102256994A Anticancer compounds
11/23/2011	CN102256618A Combination of an insulin and a glp-1 agonist
11/23/2011	CN102256617A Annexin and its use to treat inflammatory disorders
11/23/2011	CN102256616A Combination therapy with peptide epoxyketones
11/23/2011	CN102256615A Peptidomimetic macrocycles
11/23/2011	CN102256614A Synthetic mimetics of host defense and uses thereof
11/23/2011	CN102256613A Polypeptide for treating or preventing adhesions
11/23/2011	CN102256598A Process for the preparation of a peptide powder form
11/23/2011	CN102256596A Liposomal composition for convection-enhanced delivery to the central nervous centre
11/23/2011	CN102256594A Modulation of toll-like receptor 8 expression by antisense oligonucleotides
11/23/2011	CN102250935A Recombinant transgenic vector carrying human insulin-like growth factor-I and use thereof
11/23/2011	CN102250918A Recombinant human interferon-like proteins
11/23/2011	CN102250914A Protein for treating ocular vascular proliferation
11/23/2011	CN102250255A Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof
11/23/2011	CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications
11/23/2011	CN102250253A Fusogenic peptide containing thrombin fragment
11/23/2011	CN102250251A Polyethylene glycol derivative of enkephalin analogue
11/23/2011	CN102250242A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
11/23/2011	CN102250234A Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof
11/23/2011	CN102250233A Royal jelly polypeptide and application thereof
11/23/2011	CN102250225A Antimicrobial polyperptides from pseudoplectania nigrella
11/23/2011	CN102250223A Molecular improved apoptin (30-121) as well as preparation method and application thereof
11/23/2011	CN102250221A Vancomycin derivate, and preparation method and application thereof
11/23/2011	CN102250217A Hyla simplex skin injury repair promotion polypeptides and genes as well as application thereof
11/23/2011	CN102250216A Rana nigromaculata antimicrobial peptide as well as gene and application thereof
11/23/2011	CN102250214A Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy
11/23/2011	CN102250213A Matrix metalloproteinase-9 polypeptide inhibitor 3 and application thereof
11/23/2011	CN102250212A Matrix metalloproteinase-9 polypeptide inhibitor 5 and use thereof
11/23/2011	CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same
11/23/2011	CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide
11/23/2011	CN102250209A Novel HLA-A2 (Human Leukocyte Antigen-Alpha2) restrictive epitope polypeptide and application thereof
11/23/2011	CN102250208A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011	CN102250207A Novel human leukocyte antigen (HLA)-A2 limiting epitope polypeptide and use thereof
11/23/2011	CN102250206A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011	CN102250204A RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof
11/23/2011	CN102250202A 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof
11/23/2011	CN102250127A Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof

1 ... 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 ... 3163